Scrip Article: With Selective Targeting, HaemaLogiX Eyes Crowded Multiple Myeloma Space

"HaemaLogix is backing its monoclonal antibody targeting Kappa myeloma antigen to carve out space in one of oncology's most crowded markets." Read the full article here.